A randomized, comparative study of two regimens of β-artemether for the treatment of uncomplicated, Plasmodium falciparum malaria, in northern Ghana

Annals of Tropical Medicine and Parasitology

Volumn 98, Issue 5, 2004, Pages 433-440

  Oduro, A R ^a,b   Anyorigiya, T ^a   Adjuik, M ^a   Afful, T M ^b   Anto, F ^a   Atuguba, F ^a,b   Owusu Agyei, S ^a   Hodgson, A ^a  

^a NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^b Navrongo War Memorial Hospital   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEETHER; HEMOGLOBIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD SMEAR; CLEARANCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GHANA; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OPEN STUDY; PARASITEMIA; PARASITOLOGY; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITEMIA; SESQUITERPENES; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 3242712959     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349804225003532     Document Type: Article

References (16)

1. Adjuik, M., Babiker, A., Garner, P., Olliaro, P., Taylor, W. & White, N. (2004). International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet, 363, 9-17.
2. Afari, E. A., Akanmori, B. D., Nakano, T. & Ofori-Adjei, D. (1992). Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 231-232.
3. Ahmed, K. (1999). Epidemiology of malaria in Ghana. Ghana Medical Journal, 23, 190-196.
4. Binka, F. N., Morris, S. S., Ross, D. A., Arthur, P. & Aryeetey, M. E. (1994). Patterns of malaria morbidity and mortality in children in northern Ghana. Transactions of the Royal Society of Tropical Meicine and Hygiene, 88, 381-385.
5. Bunnag, D., Karbwang, J. & Harinasuta, T. (1992). Artemether in the treatment of multiple drug resistant falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health, 23, 762-767.
6. Driessen, G. J., van Kerkhoven, S., Schouwenberg, B. J., Bonsu, G. & Verhave, J. P. (2002). Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Tropical Medicine and International Health, 7, 577-583.
7. Ehrhardt, S., Mockenhaupt, F. P., Agana-Nsiire, P., Mathieu, A., Anemana, S. D., Stark, K., Otchwemah, R. N. & Bienzle, U. (2002). Efficacy of chloroquine in the treatment of uncomplicated, P. falciparum malaria in northern Ghana. Annals of Tropical Medicine and Parasitology, 96, 239-247.
8. Karbwang, J., Na-Bangchang, K., Congpuong, K., Molunto, P. & Thanavibul, A. (1997). Pharmacokinetics and bioavailability of oral and intramuscular artemether. European Journal of Clinical Pharmacology, 52, 307-310.
9. Looareesuwan, S. (1994). Overview of clinical studies on artemisinin derivatives in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88 (Suppl. 1), 9-11.
10. Mockenhaupt, F. P., Eggelte, T. A., Till, H. & Bienzle, U. (2001). Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine-resistance mutation in isolates from Ghana. Tropical Medicine and International Health, 6, 749-755.
11. Neequaye, J. (1986). In vivo chloroquine-resistant falciparum malaria in western Africa. Lancet, i, 153.
12. Owusu-Agyei, S., Koram, K. A., Baird, J. K., Utz, G. C., Binka, F. N., Nkrumah, F. K., Fryauff, D. J. & Hoffman, S. L. (2001). Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. American Journal of Tropical Medicine and Hygiene, 65, 197-203.
13. Price, R. N. (2000). Artemisinin drugs: novel anti-malarial agents. Expert Opinion on Investigational Drugs, 9, 1815-1827.
14. Suputtamongkol, Y., Newton, P. N., Angus, B., Teja-Isavadharm, P., Keeratithakul, D., Rasameesoraj, M., Pukrittayakamee, S. & White, N. J. (2001). A comparison of oral artesunate and artemether anti-malarial bioactivities in acute falciparum malaria. British Journal of Clinical Pharmacology, 52, 655-661.
15. Warhurst, D. (1997). Drug treatment and the control of malaria in Africa: a time of hope? African Health, 19, 21-23.
16. White, N. (1999). Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society of London, Series B, 354, 739-749.